Insulin resistance and metabolic syndrome in primary gout: Relation to punched-out erosions

International Journal of Rheumatic Diseases

Volumn 15, Issue 6, 2012, Pages 521-525

  Gheita, Tamer A ^a   El Fishawy, Hussein S ^a   Nasrallah, Mohamed M ^a   Hussein, Hani ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Erosions; Gout; HOMA B; HOMA IR; Insulin resistance; Metabolic syndrome

Indexed keywords

INSULIN; URIC ACID;

ADULT; ARTICLE; BONE EROSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GOUT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; METATARSOPHALANGEAL JOINT; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; GOUT; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; METATARSOPHALANGEAL JOINT; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; URIC ACID;

EID: 84871411005     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12007     Document Type: Article

References (20)

1. Bieber JD, Terkeltaub RA (2004) Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 50, 2400-14.
2. Doherty M (2009) New insights into the epidemiology of gout. Rheumatology (Oxford) 48 (Suppl 2), ii2-8.
3. Smith EU, Díaz-Torné C, Perez-Ruiz F, March LM (2010) Epidemiology of gout: an update. Best Pract Res Clin Rheumatol 24, 811-27.
4. Richette P, Bardin T (2010) Gout. Lancet 375, 318-28.
5. Ning TC, Keenan RT (2010) Unusual clinical presentations of gout. Curr Opin Rheumatol 22, 181-7.
6. Choi HK (2010) A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 22, 165-72.
7. Pereira RM, de Carvalho JF, Bonfá E (2009) Metabolic syndrome in rheumatological diseases. Autoimmun Rev 8, 415-9.
8. Sari I, Akar S, Pakoz B et al. (2009) Hyperuricemia and its related factors in an urban population, Izmir, Turkey. Rheumatol Int 29, 869-74.
9. Liese AD, Mayer-Davis EJ, Haffner SM (1998) Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 20, 157-72.
10. Bonora E, Formentini G, Calcaterra F et al. (2002) HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25, 1135-41.
11. Pillinger MH, Goldfarb DS, Keenan RT (2010) Gout and its comorbidities. Bull NYU Hosp Jt Dis 68, 199-203.
12. Yoo HG, Lee SI, Chae HJ, Park SJ, Lee YC, Yoo WH (2011) Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis. Rheumatol Int 31, 485-91.
13. Dirken-Heukensfeldt KJ, Teunissen TA, van de Lisdonk H, Lagro Janssen AL (2010) "Clinical features of women with gout arthritis." A systematic review. Clin Rheumatol 29, 575-82.
14. Hernández-Cuevas CB, Roque LH, Huerta-Sil G et al. (2009) First acute gout attacks commonly precede features of the metabolic syndrome. J Clin Rheumatol 15, 65-7.
15. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 64, 267-72.
16. Perez-Ruiz F, Dalbeth N, Urresola A, de Miguel E, Schlesinger N (2009) Imaging of gout: findings and utility. Arthritis Res Ther 11, 232.
17. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486-97.
18. Roddy E, Zhang W, Doherty M (2008) The changing epidemiology of gout. Nat Clin Pract Rheumatol 3, 443-9.
19. Eliseev MS, Barskova VG (2008) Metabolic syndrome in gout. Vestn Ross Akad Med Nauk 6, 29-32.
20. Inokuchi T, Tsutsumi Z, Takahashi S, Ka T, Moriwaki Y, Yamamoto T (2010) Increased frequency of metabolic syndrome and its individual metabolic abnormalities in Japanese patients with primary gout. J Clin Rheumatol 16, 109-12.